Stephens & Co. Maintains Equal-Weight on Tenet Healthcare, Raises Price Target to $89
Portfolio Pulse from jenniferd'souza@benzinga.com
Stephens & Co. analyst Scott Fidel maintains an Equal-Weight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $87 to $89.
August 01, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. maintains an Equal-Weight rating on Tenet Healthcare and raises the price target from $87 to $89.
The raised price target by Stephens & Co. indicates a positive outlook for Tenet Healthcare. This could potentially lead to an increase in the stock price in the short term as it signals the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100